Orlowski S, Selosse M A, Boudon C, Micoud C, Mir L M, Belehradek J, Garrigos M
Section de Biophysique des Protéines et des Membranes, DBCM, CEA, and URA 2096 CNRS, Gif/Yvette, France.
Cancer Biochem Biophys. 1998 Jun;16(1-2):85-110.
P-glycoprotein (P-gp), a plasma membrane glycoprotein associated with the multidrug resistance phenotype, is responsible for the ATP-dependent efflux of various amphiphilic drugs. Using membrane vesicles prepared from the multidrug resistant cell line DC-3F/ADX, we studied the perturbation of the basal (i.e. in the absence of drug) and verapamil-dependent P-gp ATPase activities induced by various detergents, at non-solubilizing, as well as at solubilizing, concentrations. The progressive membrane solubilization with increasing detergent concentration was monitored by light scattering and centrifugation experiments. For non-solubilizing detergent concentrations, all tested detergents except DOC induced a partial inhibition of P-gp ATPase activity, which was not correlated with the amount of the various tested detergents incorporated in the membranes. Analysis of the verapamil-induced P-gp activation reveals that P-gp ATPase activity is differently modulated by the various detergents at non-solubilizing concentrations. Thus, specific interactions between P-gp and detergents are more likely to occur rather than a global membrane perturbation. After solubilization by the various tested detergents, the basal P-gp ATPase activity was virtually completely inhibited, except in the presence of CHAPS which was able to preserve this activity at a level comparable to that measured in native membranes. However, the verapamil-induced P-gp ATPase activation was lost during P-gp solubilization by CHAPS, but recovered after dilution of CHAPS below its critical micellar concentration. These observations indicate specific interactions between P-gp and CHAPS molecules within the mixed micelles. On the whole, our data evidencing specific interactions P-gp/detergents are consistent with the location of the drug transport sites on P-gp transmembrane domains.
P-糖蛋白(P-gp)是一种与多药耐药表型相关的质膜糖蛋白,负责多种两亲性药物的ATP依赖性外排。我们使用从多药耐药细胞系DC-3F/ADX制备的膜囊泡,研究了在非增溶浓度以及增溶浓度下,各种去污剂对基础(即在无药物情况下)和维拉帕米依赖性P-gp ATP酶活性的扰动。通过光散射和离心实验监测随着去污剂浓度增加膜的逐步增溶情况。对于非增溶去污剂浓度,除了脱氧胆酸钠(DOC)外,所有测试的去污剂都诱导了P-gp ATP酶活性的部分抑制,这与掺入膜中的各种测试去污剂的量无关。对维拉帕米诱导的P-gp激活的分析表明,在非增溶浓度下,各种去污剂对P-gp ATP酶活性的调节方式不同。因此,P-gp与去污剂之间更可能发生特异性相互作用,而不是整体的膜扰动。在用各种测试去污剂增溶后,基础P-gp ATP酶活性几乎完全被抑制,除了在存在3-[(3-胆酰胺丙基)二甲氨基]-1-丙磺酸(CHAPS)的情况下,CHAPS能够将该活性维持在与天然膜中测得的水平相当的水平。然而,在CHAPS增溶P-gp的过程中,维拉帕米诱导的P-gp ATP酶激活丧失,但在将CHAPS稀释至其临界胶束浓度以下后恢复。这些观察结果表明在混合胶束中P-gp与CHAPS分子之间存在特异性相互作用。总体而言,我们证明P-gp/去污剂之间存在特异性相互作用的数据与药物转运位点在P-gp跨膜结构域上的定位一致。